The same effect was observed in these cancer cell lines following depletion of GSK3β expression by treatment with a specific small interfering RNA (siRNA), whereby depletion efficiency was confirmed by immunoblotting (Supplementary Figure 2B). This evidence concerns the gene GSK3B and cancer.